[ Skip to Main Content ]

Publications

Only 57% of the world’s women can make choices in all three areas:
👉🏾sexual intercourse with their partner
👉🏾contraception use
👉🏾health care
#SWOP2019 #SRHR https://t.co/gGfcDdv7Gp via @UNFPA @reliefweb

Delighted to celebrate the @FP2020Global Reference Group and our global SRH progress & priorities, including @EngenderHealth’s commitment to work with young people on SRHR!

Highlights from @UNFPA report:
1) 214 million women can’t access contraceptives
2) 4 in 10 women fear saying no to sexual demands
3) 59% of women use modern contraceptives, up 6% from 25 years ago
#SWOP2019 #SRHR https://t.co/A1OvRILmZz

In our last fiscal year, over 17,000 healthcare providers have gained access to tools, knowledge, and expertise to provide millions of women with the sexual and reproductive healthcare they need to thrive. #SRHR

@EngenderHealth #Tanzania &#ThaminiUhai with the generous support of @BloombergDotOrg have been working jointly with the government in Kigoma to improve maternal health by tupgrading health centers, providing CEMonC training and mentorship to staff and creating public awareness

New study finds that women in Africa face higher risks of death from C-sections mainly due to understaffed hospitals and under-trained doctors. https://t.co/PRpQngkcIE #maternalhealth

Every day approx 830 women die from preventable causes related to pregnancy. EngenderHealth is committed to changing this. We equip health facilities with well-trained staff and medical supplies to give women the high-quality #maternalhealthcare they deserve. #IntlMHDay

Lauri Romanzi @DrRomanzi, Project Director of @EngenderHealth USAID funded Fistula Care Plus project, will speak about revising a strategy to end fistula within a generation at #RCOG2019.
Find out more: https://t.co/zhJKKbyOW4

When mothers thrive, families thrive, communities thrive and nations thrive. Thanks to our amazing partners, #Tanzania Ministry of Health, PORALG, @ThaminiUhai @EngenderHealth, @VitalStrat and @CDCGlobal for all you do to support mothers. https://t.co/HIIHWiaNIa

@EngenderHealth a organisé en #CôtedIvoire un Meet-up sur les Droits en Santé sexuelle et reproductive #SSR à l’endroit des acteurs de la société civile, œuvrant dans cet univers sur les pratiques d’avortement.
#PO2019
https://t.co/CvrN6HORiA

Load More...

Postpartum Hemorrhage – Pubs Maternal Health

Community-Based Distribution of Misoprostol for the Prevention of Postpartum Hemorrhage: Evaluation of a Pilot Intervention in Tangail District, Bangladesh
The leading causes of maternal mortality are hemorrhage, eclampsia, abortion, injuries, sepsis, and obstructed labor. Deaths related to postpartum hemorrhage (PPH) present a major challenge to health systems, particularly in rural areas of Bangladesh, where infrastructure is poor and health facilities often lack skilled staff, drugs, and equipment. Misoprostol is a proven uterotonic drug that is increasingly used in clinical and home delivery settings to prevent and manage PPH.  In 2008, the Mayer Hashi/RESPOND Project implemented a pilot project in the Tangail District of Bangladesh to determine the effectiveness of using government and nongovernmental field workers at the community level to distribute misoprostol tablets and ensure that women take the drug immediately postpartum. This evaluation report discusses the process, approaches, and strategies followed in the implementation of the pilot project and uses a review of relevant project documents and activity reports, as well as interviews and focus group discussions with clients, service providers, supervisors, and program managers. The overall goal of the evaluation was to assess the effectiveness of the community-based misoprostol intervention program strategies and to gather lessons learned and provide recommendations for the national scale-up.
(2010) Download as a PDF (2.4MB) from the RESPOND Project

Preventing Postpartum Hemorrhage: Community-Based Distribution of Misoprostol in Tangail District, Bangladesh
Deaths related to postpartum hemorrhage (PPH) present a major challenge to health systems, particularly in rural areas of Bangladesh, where infrastructure is poor and health facilities often lack skilled staff, drugs, and equipment. Misoprostol is a proven uterotonic drug that is increasingly used in clinical and home delivery settings to prevent and manage PPH. This project brief discusses the implementation of a pilot project in the Tangail District of Bangladesh to determine the effectiveness of using government and nongovernmental field workers at the community level to distribute misoprostol tablets and ensure that women take the drug immediately postpartum. In addition to the programmatic intervention strategies, it looks at health outcomes, women’s views and experiences, as well as lessons learned and recommendations for moving forward.
(2010) Download as a PDF (3MB) from the RESPOND Project

Active Management of The Third Stage of Labor (AMTSL) Poster
This wall chart outlines the steps in active management of third stage of labor (AMTSL). This job aid is for use by service providers with the aim of standardizing the steps of AMTSL and preventing postpartum hemorrhage. It was produced jointly by EngenderHealth, PATH, and RTI International on behalf of the Prevention of Postpartum Hemorrhage Initiative (POPPHI). (2006)
Download this publication:
English (MCH-07P) (PDF, 428KB)
French (MCH-07PF) (PDF, 407KB)
Spanish (MCH-07PS) (PDF, 419KB)

Active Management of the Third Stage of Labor for Prevention of Postpartum Hemorrhage: A Fact Sheet for Policy Makers and Program Managers
This fact sheet describes active management of third stage of labor (AMTSL) for the prevention of postpartum hemorrhage, and outlines steps that can be taken by policy makers and program managers to increase the use of AMTSL at the advocacy, training, and service-delivery levels. It was produced jointly by EngenderHealth, PATH, and RTI International on behalf of the Prevention of Postpartum Hemorrhage Initiative (POPPHI).
Download this publication:
English (MCH-07F) (PDF, 70KB)
French (MCH-07FF) (PDF, 52KB)
Spanish (MCH-07FS) (PDF, 88KB)

Share this page: